AstraZeneca PLC 2018 SR
The report describes AstraZeneca's sustainability progress and challenges during 2018, focusing on three pillars: Access to healthcare, Environmental protection, and Ethics and transparency. Key highlights include reaching over 12 million people through access programs and achieving a 54% reduction in Scope 2 emissions since 2015. The company conducted a materiality refresh identifying 16 priority issues and emphasized the link between environmental health and human health. Additionally, 61% of the company's total electricity use is now sourced from renewable energy, and the company maintained a double A listing from CDP for climate and water.
Company: AstraZeneca PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2018
Type: SR
Pages: 61
AstraZeneca PLC
The report describes AstraZeneca's sustainability progress and challenges during 2018, focusing on three pillars: Access to healthcare, Environmental protection, and Ethics and transparency. Key highlights include reaching over 12 million people through access programs and achieving a 54% reduction in Scope 2 emissions since 2015. The company conducted a materiality refresh identifying 16 priority issues and emphasized the link between environmental health and human health. Additionally, 61% of the company's total electricity use is now sourced from renewable energy, and the company maintained a double A listing from CDP for climate and water.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees